tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CRDL Stock Latest News

Buy Rating for Cardiol Therapeutics: Promising Innovations in Heart Disease Treatment with CardiolRx and CRD-38
RatingsBuy Rating for Cardiol Therapeutics: Promising Innovations in Heart Disease Treatment with CardiolRx and CRD-38
24d ago
CRDL
Cardiol Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Cardiol Therapeutics initiated with a Buy at H.C. Wainwright
24d ago
CRDL
Cardiol Therapeutics Announces AGM Results and New Board Member
PremiumCompany Announcements
Cardiol Therapeutics Announces AGM Results and New Board Member
28d ago
6K
CRDL
Cardiol Therapeutics Reports Q1 2025 Financial Results
PremiumCompany Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
29d ago
CRDL
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
PremiumCompany Announcements
Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials
30d ago
6K
CRDL
Promising Clinical Developments and Investment Potential in Cardiol Therapeutics
PremiumRatingsPromising Clinical Developments and Investment Potential in Cardiol Therapeutics
1M ago
CRDL
Cardiol Therapeutics Reports Q1 2025 Financial Results
Premium
Company Announcements
Cardiol Therapeutics Reports Q1 2025 Financial Results
1M ago
6K
CRDL
Promising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
Premium
Ratings
Promising Prospects for Cardiol Therapeutics: Buy Rating Backed by Strong Market Potential and Innovative Treatment Developments
2M ago
CRDL
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
PremiumCompany Announcements
Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress
2M ago
6K
CRDL
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
PremiumCompany Announcements
Cardiol Therapeutics Schedules Virtual Annual General Meeting for May 2025
2M ago
6K
CRDL
Buy Rating for Cardiol Therapeutics Driven by CardiolRx Progress and MAVERIC Phase 3 Trial Initiation
PremiumRatings
Buy Rating for Cardiol Therapeutics Driven by CardiolRx Progress and MAVERIC Phase 3 Trial Initiation
2M ago
CRDL
Cardiol Therapeutics Commences Phase III Trial for CardiolRx™ in Recurrent Pericarditis
PremiumCompany Announcements
Cardiol Therapeutics Commences Phase III Trial for CardiolRx™ in Recurrent Pericarditis
2M ago
CRDL
Cardiol Therapeutics Reports Increased Losses Amid Rising Expenses
PremiumCompany AnnouncementsCardiol Therapeutics Reports Increased Losses Amid Rising Expenses
2M ago
CRDL
Cardiol Therapeutics’ Advancements and Clinical Successes Drive Buy Rating and $9 Price Target
Premium
Ratings
Cardiol Therapeutics’ Advancements and Clinical Successes Drive Buy Rating and $9 Price Target
3M ago
CRDL
Cardiol Therapeutics management to meet with Oppenheimer
Premium
The Fly
Cardiol Therapeutics management to meet with Oppenheimer
3M ago
CRDL
Cardiol Therapeutics Advances Heart Disease Treatments with Promising Clinical Results
PremiumCompany Announcements
Cardiol Therapeutics Advances Heart Disease Treatments with Promising Clinical Results
3M ago
CRDL
CRDL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CRDL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CRDL
Cardiol Therapeutics Schedules Annual General Meeting for May 2025
PremiumCompany Announcements
Cardiol Therapeutics Schedules Annual General Meeting for May 2025
3M ago
6K
CRDL
Cardiol Therapeutics to Present at TD Cowen Health Care Conference
PremiumCompany Announcements
Cardiol Therapeutics to Present at TD Cowen Health Care Conference
4M ago
CRDL
Promising Potential of Cardiol Therapeutics’ CRD-38 Justifies Buy Rating Amidst Market Need for HFpEF Treatment
PremiumRatingsPromising Potential of Cardiol Therapeutics’ CRD-38 Justifies Buy Rating Amidst Market Need for HFpEF Treatment
4M ago
CRDL
Cardiol Therapeutics Advances Heart Failure Treatment with New Research Publication
Premium
Company Announcements
Cardiol Therapeutics Advances Heart Failure Treatment with New Research Publication
4M ago
CRDL
Cardiol Therapeutics to Present at Healthcare Conference, Highlighting Advances in Heart Disease Therapies
Premium
Company Announcements
Cardiol Therapeutics to Present at Healthcare Conference, Highlighting Advances in Heart Disease Therapies
5M ago
CRDL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >